Microenvironment-mediated resistance to anticancer therapies. - Wikidata - awgldk - TriplyDB

Microenvironment-mediated resistance to anticancer therapies.

Microenvironment-mediated resistance to anticancer therapies.

http://www.wikidata.org/entity/Q39286020

about

Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death Humanized anti-hepatocyte growth factor (HGF) antibody suppresses innate irinotecan (CPT-11) resistance induced by fibroblast-derived HGF.The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology.Republished: Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology.Changes in the Secretory Profile of NSCLC-Associated Fibroblasts after Ablative Radiotherapy: Potential Impact on Angiogenesis and Tumor Growth.Inflammation and uPAR-Expression in Colorectal Liver Metastases in Relation to Growth Pattern and Neo-adjuvant Therapy.The Challenges of Modeling Drug Resistance to Antiangiogenic Therapy.Cordycepin and a preparation from Cordyceps militaris inhibit malignant transformation and proliferation by decreasing EGFR and IL-17RA signaling in a murine oral cancer model.Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies.Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer.

P2860

Q28080874-2D9BB68B-AAE6-41AD-9EE8-8550CC886323 Q36414376-58FDD169-FD45-4908-AB82-0997733B86C9 Q36478715-11A34588-CB84-458D-96BE-87F2DC61FC8D Q38241160-E90EF787-4480-46C7-A35F-3F8579F412E5 Q38481540-BC012F81-2185-4A3E-A929-2B0F341A7C58 Q41810070-B4128775-4AFE-4C8C-80E4-051626B3CC66 Q41978426-4A81D454-4C31-42C3-8FC9-BBD7FB2B1488 Q44456046-1B808FD5-1C75-4AA7-A763-28ABD01DF1E1 Q47139326-F68777DD-2E68-4CA8-942B-89481995A57F Q48308048-8006C211-785E-41CA-AE82-A0A7A7FA21C0 Q49723815-E387EB67-09C9-42D7-A6C2-915EA9CF7004

P2860

Microenvironment-mediated resistance to anticancer therapies.

http://www.wikidata.org/entity/Q39286020

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Microenvironment-mediated resistance to anticancer therapies.

@en

Microenvironment-mediated resistance to anticancer therapies.

@nl

type

label

Microenvironment-mediated resistance to anticancer therapies.

@en

Microenvironment-mediated resistance to anticancer therapies.

@nl

prefLabel

Microenvironment-mediated resistance to anticancer therapies.

@en

Microenvironment-mediated resistance to anticancer therapies.

@nl

P1433

Q39286020-BC12CC08-A79F-4AF8-995B-14B541A0597F

P1476

Q39286020-D63C0456-2429-4570-972F-B0AC43C617EC

P2093

Q39286020-A31FF6AB-7C61-4941-A768-714E3FA289F5

P2860

Q39286020-049F19DB-B743-4151-93A0-68B17E70AFC4

Q39286020-24AFDEBC-4F67-4AC0-948A-DAAB2A50954D

Q39286020-28CF029B-2F05-4532-AB6F-56776AB2718A

Q39286020-307A2391-6628-4A0E-BF7D-7DD015158064

Q39286020-5DA0C658-BD43-467A-B2B5-C324E26ABE77

Q39286020-770D5F93-A0E7-4F5D-BF63-037B827E02D2

Q39286020-782FA125-FD07-4EA1-B251-23F2D5E5B011

Q39286020-81C4818D-3E9B-4E39-B060-4B191EB47E68

Q39286020-9E2F25E9-31D9-4422-8F52-1BCE224ED647

Q39286020-B9440632-4481-4C37-90FE-2E4ABA88648C

P2888

Q39286020-51A42529-A513-4BF9-A476-973BDF898841

P304

Q39286020-644F5A60-B675-4D45-BAFA-22032C20F7E5

P31

Q39286020-47220169-CECB-4692-8D0B-EFBE83BBA417

P356

Q39286020-F37871CF-07A8-4735-92DA-F339547738CD

P433

Q39286020-99E31EED-F97B-4445-A99B-211B0B294BE3

P478

Q39286020-01431A3B-869E-4734-8A76-4507A8462A2C

P50

Q39286020-897728A0-ACBE-4EDA-B514-B45F5C1C9C83

P577

Q39286020-AC6834EB-2FDF-4DF8-BF06-5FB275FB80EB

P5875

Q39286020-9B6BCE63-0B33-4108-B44C-ED99D2F35B02

P698

Q39286020-893089A6-AEDA-4AF6-92A7-28D0FF3CF68D

P932

Q39286020-1CBD54FF-DFDF-4DE2-AEFB-53C2DCBB4147

P356

P1433

P1476

Microenvironment-mediated resistance to anticancer therapies.

@en

P2093

Johanna A Joyce

http://www.w3.org/2001/XMLSchema#string

P2860

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

Microenvironmental regulation of metastasis

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)

Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.

Stromal gene expression predicts clinical outcome in breast cancer.

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.

P2888

P304

179-181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CR.2012.123

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230790875

http://www.w3.org/2001/XMLSchema#string

P698

22945358

http://www.w3.org/2001/XMLSchema#string

P932

3567818

http://www.w3.org/2001/XMLSchema#string